BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211118
DTEND;VALUE=DATE:20211219
DTSTAMP:20260515T231525
CREATED:20211018T092817Z
LAST-MODIFIED:20211018T092817Z
UID:31844-1637193600-1639871999@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China Virtual Expo Connect 2021
DESCRIPTION:Virtual Expo Connect” is the digital extension of the physical CPhI & P-MEC China event that offers an online alternative for global pharma professionals. Powered by PharmaSources.com\, Virtual Expo Connect builds an online platform to be accessed from anywhere\, adding valued services and infinite opportunities to connect\, learn\, trade and grow. \nTo know more visit: https://bit.ly/3ASODPZ
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-virtual-expo-connect-2021/
LOCATION:Online
ORGANIZER;CN="Informa Markets":MAILTO:Candice.lau@informa.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211206
DTEND;VALUE=DATE:20211210
DTSTAMP:20260515T231525
CREATED:20210817T215306Z
LAST-MODIFIED:20210817T215306Z
UID:31360-1638748800-1639094399@www.pharmajournalist.com
SUMMARY:3rd Gene Therapy for Neurological Disorders
DESCRIPTION:Returning to Boston this December\, the 3rd Gene Therapy for Neurological Disorders meeting will welcome discovery\, preclinical\, translational and clinical industry scientists to share\, learn and network for the shared goal of successfully and safely delivering gene therapies to the CNS. \nWith 40+ expert leaders from the likes of Taysha Gene Therapies\, Passage Bio\, AskBio\, Neurogene\, Affinia Therapeutics and Alcyone Therapeutics sharing their progress\, don’t miss the chance to join the industry’s definitive physical conference to make new connections and reconnect with your friends and colleagues. \nOver 4 comprehensive days of networking\, presentations and discussion sessions\, this meeting will enable you to: \n\nDiscuss the latest DRG toxicity and immunogenicity research to understand the biology behind AAV toxicity in the CNS\nEvaluate current safety and toxicity strategies to navigate off target effects including redosing options\nEvaluate intraparenchymal\, intra-cisterna magna\, lumbar intrathecal and systemic delivery routes for CNS indications to assess CNS tropism and biodistribution\nHear from neurosurgeons at the forefront of delivery and explore the most up to date delivery devices to identify novel innovations and areas for development\nReview pharmacological concepts for preclinical dose selection in NHP biodistribution case studies to optimize dose extrapolation\nLearn about the different vector discovery strategies used to identify vectors with improved CNS tropism and specificity\nOptimize clinical trial design considerations for both paediatric and adult neurological patient populations to showcase efficacy to regulators and deliver value for patients\nDiscover the novel indications being targeted by gene therapies such as epilepsy\, neuropathic pain and hearing disorders to improve your knowledge of current CNS pipelines\n\nView your copy of the event guide now: https://ter.li/yrofx9
URL:https://www.pharmajournalist.com/event/3rd-gene-therapy-for-neurological-disorders/
LOCATION:The Colonnade Hotel\, 120 Huntington Ave\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR